Citigroup
BIVI icon

Citigroup’s BioVie BIVI Stock Holding History

Citigroup’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.43K Buy
+3,164
New +$4.07K ﹤0.01% 5289
2025
Q3 		– Sell
-551
Closed -$5.1K – 6091
2025
Q2 		$5.1K Buy
+551
New +$5.44K ﹤0.01% 5277
2025
Q1 		– Hold
0
– -$4 – 5600
2024
Q4 		– Hold
0
– – – 5788
2024
Q3 		– Sell
-19
Closed -$606 – 5633
2024
Q2 		$757 Sell
19
-8
-30% -$383 ﹤0.01% 5393
2024
Q1 		$1.43K Buy
27
+7
+35% +$718 ﹤0.01% 5411
2023
Q4 		$2.54K Buy
+20
New +$6.01K ﹤0.01% 5402
2023
Q3 		– Sell
-10
Closed -$3.91K – 5431
2023
Q2 		$4.26K Sell
10
-16
-62% -$10.8K ﹤0.01% 5203
2023
Q1 		$20.7K Buy
26
+5
+24% +$3.31K ﹤0.01% 4502
2022
Q4 		$16.6K Buy
+21
New +$11.4K ﹤0.01% 4662
2021
Q2 		– Sell
-5
Closed -$9K – 6130
2021
Q1 		$9K Sell
5
-1
-17% -$2.85K ﹤0.01% 5678
2020
Q4 		$11K Buy
+6
New +$5.99K ﹤0.01% 6916

Other funds holding BIVI

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Citigroup's BIVI Position: Q1 2026 in Review

Citigroup opened a new position in BioVie (BIVI) in Q1 2026: 3,164 shares worth $4.43K. The stake represents ﹤0.01% of the portfolio and ranks #5289 among its holdings. This is a return to the name: Citigroup previously reported a position in BIVI as recently as Q2 2025.

Citigroup first reported a position in BIVI in Q4 2020 and has held it in 10 quarters since. The position peaked at $20.7K in Q1 2023. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

  • Citigroup held 3,164 shares of BioVie worth $4.43K as of Q1 2026.
  • BioVie was a new Citigroup position in Q1 2026.
  • BioVie made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5289 holding.
  • Citigroup first reported a position in BioVie in Q4 2020 and has held it in 10 quarters since.
  • Citigroup's BioVie position peaked at $20.7K in Q1 2023.
  • 33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.